Disease-modifying antirheumatic and immunoregulatory agents
Identifieur interne : 003077 ( Main/Exploration ); précédent : 003076; suivant : 003078Disease-modifying antirheumatic and immunoregulatory agents
Auteurs : K. D. RainsfordSource :
- Bailliere's Clinical Rheumatology [ 0950-3579 ] ; 1990.
English descriptors
- Teeft :
- Abstract supplement, Alternative pathway, American college, American journal, Anaemia, Animal models, Antibody production, Antiinflammatory drugs, Antimalarial, Antimalarial drugs, Antirheumatic, Antirheumatic activity, Antirheumatic drugs, Arachidonic acid, Arthritic conditions, Arthritic disease, Arthritis, Arthropathy, Autoimmune diseases, Basel, Biochemical pharmacology, Biochemical systems, Biological chemistry, Boca raton, British journal, Cartilage, Cell activation, Cell proliferation, Cell subsets, Chloroquine, Chloroquine treatment, Chronic inflammation, Clinical aspects, Clinical investigation, Clinical nephrology, Clinical pharmacology, Clinical practice, Clinical response, Combination therapy, Considerable number, Cyclosporin, Cyclosporin treatment, Cyclosporine, Cytokine, Disease activity, Disease state, Dmards, Dougados, Drug therapy, Dual inhibitor, Endocytic vesicles, Endothelial cells, England journal, Erythropoietin, European journal, Experimental agents, Experimental arthritis, Experimental medicine, First week, Further studies, Gold complexes, Gold compounds, Gold sodium thiomalate, Hazleman, Herzog, Hunneyball, Immune, Immune complexes, Immune system, Immunopathology, Immunoregulatory, Immunoregulatory agents, Inflammation, Inflammation research, Inflammatory, Inflammatory responses, Inhibitor, Inhibitory effects, Interferon, Interferon gamma, Internal medicine, International congress, Iron status, Joint destruction, Kidney mitochondria, Kluwer, Kremer, Lancaster, Lesser extent, Lyle, Lymphocyte, Lymphocyte activation, Lymphocyte proliferation, Lysosomal phospholipase, Macrophage, Macrophage differentiation, Major organ systems, Mccune, Metabolism, Methotrexate, Methylprednisolone pulse therapy, Microvascular changes, Much impetus, Much interest, Multiple sclerosis, Nash, National academy, Neutrophil, Nsaid, Other agents, Other cells, Other cytokines, Other dmards, Other thiols, Oxyradical production, Passive transfer, Pathogenesis, Paulus, Pharmacological actions, Pharmacology, Pilot study, Placebo, Plasma cells, Putative organisms, Radiological changes, Rainsford, Raven press, Recent developments, Recent studies, Recent years, Receptor, Receptor expression, Renal, Renal function, Renal production, Rheumatic, Rheumatic condition, Rheumatic disease, Rheumatic diseases, Rheumatism, Rheumatoid, Rheumatoid arthritis, Rheumatoid arthritis patients, Rheumatoid factors, Rheumatology, Sasp, Satellite meeting, Scandinavian journal, Selective action, Shiroky, Side effects, Significant improvement, Spleen cells, Springer seminars, Stecher, Subset, Sulphasalazine, Superoxide, Synovial, Synovial fluid, Synovial tissues, Therapeutic drug monitoring, Therapeutic intervention, Therapeutic response, Therapy, Thiol reactivity, Thromboxane production, Toxic effects, Toxicity, Traditional drugs, Transplantation proceedings, Tugwell, Velo, Weinblatt, Whitehouse.
Url:
DOI: 10.1016/S0950-3579(05)80002-0
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000130
- to stream Istex, to step Curation: 000130
- to stream Istex, to step Checkpoint: 001E48
- to stream Main, to step Merge: 003146
- to stream Main, to step Curation: 003077
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Disease-modifying antirheumatic and immunoregulatory agents</title>
<author><name sortKey="Rainsford, K D" sort="Rainsford, K D" uniqKey="Rainsford K" first="K. D." last="Rainsford">K. D. Rainsford</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E4156C93B8871D2495DCCE420B622FD467C43313</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1016/S0950-3579(05)80002-0</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-SPZC5VB6-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000130</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000130</idno>
<idno type="wicri:Area/Istex/Curation">000130</idno>
<idno type="wicri:Area/Istex/Checkpoint">001E48</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001E48</idno>
<idno type="wicri:doubleKey">0950-3579:1990:Rainsford K:disease:modifying:antirheumatic</idno>
<idno type="wicri:Area/Main/Merge">003146</idno>
<idno type="wicri:Area/Main/Curation">003077</idno>
<idno type="wicri:Area/Main/Exploration">003077</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Disease-modifying antirheumatic and immunoregulatory agents</title>
<author><name sortKey="Rainsford, K D" sort="Rainsford, K D" uniqKey="Rainsford K" first="K. D." last="Rainsford">K. D. Rainsford</name>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Bailliere's Clinical Rheumatology</title>
<title level="j" type="abbrev">BACR</title>
<idno type="ISSN">0950-3579</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1990">1990</date>
<biblScope unit="volume">4</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="405">405</biblScope>
<biblScope unit="page" to="432">432</biblScope>
</imprint>
<idno type="ISSN">0950-3579</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0950-3579</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abstract supplement</term>
<term>Alternative pathway</term>
<term>American college</term>
<term>American journal</term>
<term>Anaemia</term>
<term>Animal models</term>
<term>Antibody production</term>
<term>Antiinflammatory drugs</term>
<term>Antimalarial</term>
<term>Antimalarial drugs</term>
<term>Antirheumatic</term>
<term>Antirheumatic activity</term>
<term>Antirheumatic drugs</term>
<term>Arachidonic acid</term>
<term>Arthritic conditions</term>
<term>Arthritic disease</term>
<term>Arthritis</term>
<term>Arthropathy</term>
<term>Autoimmune diseases</term>
<term>Basel</term>
<term>Biochemical pharmacology</term>
<term>Biochemical systems</term>
<term>Biological chemistry</term>
<term>Boca raton</term>
<term>British journal</term>
<term>Cartilage</term>
<term>Cell activation</term>
<term>Cell proliferation</term>
<term>Cell subsets</term>
<term>Chloroquine</term>
<term>Chloroquine treatment</term>
<term>Chronic inflammation</term>
<term>Clinical aspects</term>
<term>Clinical investigation</term>
<term>Clinical nephrology</term>
<term>Clinical pharmacology</term>
<term>Clinical practice</term>
<term>Clinical response</term>
<term>Combination therapy</term>
<term>Considerable number</term>
<term>Cyclosporin</term>
<term>Cyclosporin treatment</term>
<term>Cyclosporine</term>
<term>Cytokine</term>
<term>Disease activity</term>
<term>Disease state</term>
<term>Dmards</term>
<term>Dougados</term>
<term>Drug therapy</term>
<term>Dual inhibitor</term>
<term>Endocytic vesicles</term>
<term>Endothelial cells</term>
<term>England journal</term>
<term>Erythropoietin</term>
<term>European journal</term>
<term>Experimental agents</term>
<term>Experimental arthritis</term>
<term>Experimental medicine</term>
<term>First week</term>
<term>Further studies</term>
<term>Gold complexes</term>
<term>Gold compounds</term>
<term>Gold sodium thiomalate</term>
<term>Hazleman</term>
<term>Herzog</term>
<term>Hunneyball</term>
<term>Immune</term>
<term>Immune complexes</term>
<term>Immune system</term>
<term>Immunopathology</term>
<term>Immunoregulatory</term>
<term>Immunoregulatory agents</term>
<term>Inflammation</term>
<term>Inflammation research</term>
<term>Inflammatory</term>
<term>Inflammatory responses</term>
<term>Inhibitor</term>
<term>Inhibitory effects</term>
<term>Interferon</term>
<term>Interferon gamma</term>
<term>Internal medicine</term>
<term>International congress</term>
<term>Iron status</term>
<term>Joint destruction</term>
<term>Kidney mitochondria</term>
<term>Kluwer</term>
<term>Kremer</term>
<term>Lancaster</term>
<term>Lesser extent</term>
<term>Lyle</term>
<term>Lymphocyte</term>
<term>Lymphocyte activation</term>
<term>Lymphocyte proliferation</term>
<term>Lysosomal phospholipase</term>
<term>Macrophage</term>
<term>Macrophage differentiation</term>
<term>Major organ systems</term>
<term>Mccune</term>
<term>Metabolism</term>
<term>Methotrexate</term>
<term>Methylprednisolone pulse therapy</term>
<term>Microvascular changes</term>
<term>Much impetus</term>
<term>Much interest</term>
<term>Multiple sclerosis</term>
<term>Nash</term>
<term>National academy</term>
<term>Neutrophil</term>
<term>Nsaid</term>
<term>Other agents</term>
<term>Other cells</term>
<term>Other cytokines</term>
<term>Other dmards</term>
<term>Other thiols</term>
<term>Oxyradical production</term>
<term>Passive transfer</term>
<term>Pathogenesis</term>
<term>Paulus</term>
<term>Pharmacological actions</term>
<term>Pharmacology</term>
<term>Pilot study</term>
<term>Placebo</term>
<term>Plasma cells</term>
<term>Putative organisms</term>
<term>Radiological changes</term>
<term>Rainsford</term>
<term>Raven press</term>
<term>Recent developments</term>
<term>Recent studies</term>
<term>Recent years</term>
<term>Receptor</term>
<term>Receptor expression</term>
<term>Renal</term>
<term>Renal function</term>
<term>Renal production</term>
<term>Rheumatic</term>
<term>Rheumatic condition</term>
<term>Rheumatic disease</term>
<term>Rheumatic diseases</term>
<term>Rheumatism</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatoid arthritis patients</term>
<term>Rheumatoid factors</term>
<term>Rheumatology</term>
<term>Sasp</term>
<term>Satellite meeting</term>
<term>Scandinavian journal</term>
<term>Selective action</term>
<term>Shiroky</term>
<term>Side effects</term>
<term>Significant improvement</term>
<term>Spleen cells</term>
<term>Springer seminars</term>
<term>Stecher</term>
<term>Subset</term>
<term>Sulphasalazine</term>
<term>Superoxide</term>
<term>Synovial</term>
<term>Synovial fluid</term>
<term>Synovial tissues</term>
<term>Therapeutic drug monitoring</term>
<term>Therapeutic intervention</term>
<term>Therapeutic response</term>
<term>Therapy</term>
<term>Thiol reactivity</term>
<term>Thromboxane production</term>
<term>Toxic effects</term>
<term>Toxicity</term>
<term>Traditional drugs</term>
<term>Transplantation proceedings</term>
<term>Tugwell</term>
<term>Velo</term>
<term>Weinblatt</term>
<term>Whitehouse</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Rainsford, K D" sort="Rainsford, K D" uniqKey="Rainsford K" first="K. D." last="Rainsford">K. D. Rainsford</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003077 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003077 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:E4156C93B8871D2495DCCE420B622FD467C43313 |texte= Disease-modifying antirheumatic and immunoregulatory agents }}
This area was generated with Dilib version V0.6.33. |